Daiichi Closes Ranbaxy Deal for $4.15 Billion

Daiichi Sankyo (Tokyo) says it has completed the acquisition of a majority stake in India’s largest pharmaceutical company, Ranbaxy Laboratories (Gurgaon, India), with the final transfer of the remaining equity shares of Ranbaxy’s founders, the Singh family. Daiichi Sankyo now holds 63.92% of Ranbaxy and paid a total of about $4.15 billion for the stake. Malvinder Singh, head of Ranbaxy, shakes on the deal with Takashi Shoda, head of Daiichi Sankyo. Daiichi Sankyo signed a deal with Ranbaxy last June to acquire the shares from the Singh family and...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers